Characteristics and prognosis of chromophobe non-metastatic renal cell carcinoma: A multicenter study

International Journal of Urology

Volumn 17, Issue 11, 2010, Pages 898-904

  Lee, Won Ki ^a   Byun, Seok Soo ^b   Kim, Hyeon Hoe ^b   Rha, Koon Ho ^c   Hwang, Tae Kon ^d   Sung, Gyung Tak ^e   Lee, Wan ^f   Lim, Jae Sung ^g   Jeong, Young Beom ^h   Kwon, Tae Gyun ⁱ  

^a Hallym University   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

^d The Catholic University of Korea   (South Korea)

^e Dong A University   (South Korea)

^f Pusan National University School of Medicine   (South Korea)

^g Chungnam National University   (South Korea)

^h Chonbuk National University   (South Korea)

ⁱ Kyungpook National University School of Medicine   (South Korea)

Author keywords

Chromophobe; Conventional; Pathology; Renal cell carcinoma; Survival

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; CANCER GRADING; CANCER RECURRENCE; CANCER SIZE; CANCER SURVIVAL; CHILD; DISEASE FREE SURVIVAL; EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; PARTIAL NEPHRECTOMY; PRIORITY JOURNAL; PROGNOSIS; RATING SCALE; RETROSPECTIVE STUDY; SCHOOL CHILD; SEX RATIO; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANALYSIS OF VARIANCE; BIOPSY, NEEDLE; CARCINOMA, RENAL CELL; COHORT STUDIES; COMBINED MODALITY THERAPY; CONFIDENCE INTERVALS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEPHRECTOMY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEX FACTORS; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 77958587212     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2010.02630.x     Document Type: Article

References (31)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J. Clin. 2009; 59: 225-49.
2. Campbell SC, Novick AC, Bukowski RM. Renal tumor. In: Walsh PC, Retik AB, Vaughan ED, Wein AJ (eds). Campbell-Walsh Urology. WB Saunders, Philadelphia, PA, 2007; 2762-72.
3. Lam JS, Leppert JT, Figlin RA, Belldegrun AS. Surveillance following radical or partial nephrectomy for renal cell carcinoma. Curr. Urol. Rep. 2005; 6: 7-18.
4. Cindolo L, Patard JJ, Chiodini P et al. Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy. Cancer 2005; 104: 1362-71.
5. Kattan MW, Reuter V, Motzer RJ, Katz J, Russo P. A postoperative prognostic nomogram for renal cell carcinoma. J. Urol. 2001; 166: 63-7.
6. Patard JJ, Kim HL, Lam JS et al. Use of the University of California Los Angeles integrated staging system to predict survival in renal cell carcinoma: an international multicenter study. J. Clin. Oncol. 2004; 22: 3316-22.
7. Shuch BM, Lam JS, Belldegrun AS, Figlin RA. Prognostic factors in renal cell carcinoma. Semin. Oncol. 2006; 33: 563-75.
8. Raj GV, Thompson RH, Leibovich BC, Blute ML, Russo P, Kattan MW. Preoperative nomogram predicting 12-year probability of metastatic renal cancer. J. Urol. 2008; 179: 2146-51.
9. Kovacs G, Akhtar M, Beckwith BJ et al. The Heidelberg classification of renal cell tumours. J. Pathol. 1997; 183: 131-3.
10. Schuetz AN, Yin-Goen Q, Amin MB et al. Molecular classification of renal tumors by gene expression profiling. J. Mol. Diagn. 2005; 7: 206-18.
11. Furge KA, Lucas KA, Takahashi M et al. Robust classification of renal cell carcinoma based on gene expression data and predicted cytogenetic profiles. Cancer Res. 2004; 64: 4117-21.
12. Cohen HT, McGovern FJ. Renal-cell carcinoma. N. Engl. J. Med. 2005; 353: 2477-90.
13. Delahunt B, Bethwaite RB, Nacey JN. Outcome prediction for renal cell carcinoma: evaluation of prognostic factors for tumours divided according to histological subtype. Pathology 2007; 39: 459-65.
14. Beck SD, Patel MI, Snyder ME et al. Effect of papillary and chromophobe cell type on disease-free survival after nephrectomy for renal cell carcinoma. Ann. Surg. Oncol. 2004; 11: 71-7.
15. Patard JJ, Leray E, Rioux-Leclercq N et al. Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. J. Clin. Oncol. 2005; 23: 2763-71.
16. Teloken PE, Thompson RH, Tickoo SK et al. Prognostic impact of histological subtype on surgically treated localized renal cell carcinoma. J. Urol. 2009; 182: 2132-6.
17. Klatte T, Han K, Said JW et al. Pathobiology and prognosis of chromophobe renal cell carcinoma. Urol. Oncol. 2008; 26: 604-9.
18. Greene FL, Page DL, Flemming ID. AJCC Cancer Staging Manual, 6th edn. Springer, New York, 2002; 323.
19. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am. J. Surg. Pathol. 1982; 6: 655.
20. Eble JN, Sauter G, Epstein JI et al. Tumours of the kidney. In: Eble JN, Sauter G, Epstein JI (eds). WHO Classification of Tumours: Tumours of the Urinary System and Male Genital Organs. IARC Press, Lyon, 2004; 12.
21. Delahunt B, Eble JN. Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors. Mod. Pathol. 1997; 10: 537-44.
22. Pignot G, Elie C, Conquy S et al. Survival analysis of 130 patients with papillary renal cell carcinoma: prognostic utility of type 1 and type 2 subclassification. Urology 2007; 69: 230-35.
23. Stec R, Grala B, Maczewski M, Bodnar L, Szczylik C. Chromophobe renal cell cancer: Review of the literature and potential methods of treating metastatic disease. J. Exp. Clin. Cancer Res. 2009; 28: 134-9.
24. Kim H, Cho NH, Kim DS et al. Renal cell carcinoma in South Korea: a multicenter study. Hum. Pathol. 2004; 35: 1556-63.
25. Capitanio U, Cloutier V, Zini L et al. A critical assessment of the prognostic value of clear cell, papillary and chromophobe histological subtypes in renal cell carcinoma: a population-based study. BJU Int. 2009; 103: 1496-500.
26. Tickoo SK, Gopalan A. Pathologic features of renal cortical tumors. Urol. Clin. North Am. 2008; 35: 551-61.
27. Leibovich BC, Lohse CM, Crispen PL et al. Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma. J. Urol. 2010; 183: 1309-16.
28. Karakiewicz PI, Briganti A, Chun FKH et al. Multi-institutional validation of a new renal cancer-specific survival nomogram. J. Clin. Oncol. 2007; 25: 1316-22.
29. Waldert M, Klatte T, Haitel A et al. Hybrid renal cell carcinomas containing histopathologic features of chromophobe renal cell carcinomas and oncocytomas have excellent oncologic outcomes. Eur. Urol. 2010; 57: 661-6.
30. Eichelberg C, Junker K, Ljungberg B, Moch H. Diagnostic and prognostic molecular markers for renal cell carcinoma: a critical appraisal of the current state of research and clinical applicability. Eur. Urol. 2009; 55: 851-63.
31. Amin MB, Paner GP, Alvarado-Cabrero I et al. Chromophobe renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 145 cases. Am. J. Surg. Pathol. 2008; 32: 1822-34.